HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is amoxicillin-cotrimoxazole the most appropriate antibiotic regimen for listeria meningoencephalitis? Review of 22 cases and the literature.

Abstract
From June 1983 to January 1994, 22 adult patients with severe Listeria monocytogenes meningoencephalitis were observed in our Intensive Care Unit. Listeria monocytogenes was obtained in culture in cerebrospinal fluid or blood for every patient. Seven patients were treated with the combination ampicillin-aminoglycoside (group A) and 15 patients with the combination ampicillin (or amoxicillin)-cotrimoxazole (group A + C). Risk factors and gravity scores were similar in both groups. Failure of the 'gold standard' regimen (group A) was significantly higher (57%) compared to group A + C (6.7%) (P < 0.05). Mortality related to L. monocytogenes was 23.5% in group A compared to 6.7% in group A + C. Morbidity was reduced in group A + C (13.3%) compared to group A (60%) (P = 0.15). This unique study seems to demonstrate that amoxicillin-cotrimoxazole should be the most appropriate therapeutic regimen for Listeria meningoencephalitis.
AuthorsM Merle-Melet, L Dossou-Gbete, P Maurer, P Meyer, A Lozniewski, O Kuntzburger, M Wéber, A Gérard
JournalThe Journal of infection (J Infect) Vol. 33 Issue 2 Pg. 79-85 (Sep 1996) ISSN: 0163-4453 [Print] England
PMID8889993 (Publication Type: Journal Article)
Chemical References
  • Amoxicillin
  • Trimethoprim, Sulfamethoxazole Drug Combination
Topics
  • Adult
  • Aged
  • Amoxicillin (therapeutic use)
  • Child
  • Drug Therapy, Combination (therapeutic use)
  • Female
  • Humans
  • Listeriosis (drug therapy)
  • Male
  • Meningoencephalitis (drug therapy)
  • Middle Aged
  • Trimethoprim, Sulfamethoxazole Drug Combination (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: